cas 2970213-45-5|| where to buy 3-(2-bromo-7-oxo-4,5-dihydrothieno[2,3-c]pyridin-6-yl)piperidine-2,6-dione

Nom du produit:3-(2-bromo-7-oxo-4,5-dihydrothieno[2,3-c]pyridin-6-yl)piperidine-2,6-dione

IUPAC Name:3-{2-bromo-7-oxo-4H,5H,6H,7H-thieno[2,3-c]pyridin-6-yl}piperidine-2,6-dione

: CAS：2970213-45-5; Formule moléculaire：C12H11BrN2O3S; Pureté：97%

Unité d'emballage	Stock disponible	Prix($)
CM1076101-100mg	in stock	Ȑŵƿ
CM1076101-250mg	in stock	ũȐŵ
CM1076101-500mg	in stock	ƃȐũȐ
CM1076101-1g	in stock	ƥƛũƛ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:2970213-45-5; Formule moléculaire:C12H11BrN2O3S; Point de fusion:-; Code SMILES:BrC1=CC2=C(S1)C(=O)N(CC2)C1CCC(=O)NC1=O; Densité:

: Numéro de catalogue:CM1076101; Poids moléculaire:343.2; Point d'ébullition:; N° Mdl:; Stockage:

: PROTAC-E3 Ligase Ligands; Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.; PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.